BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32652429)

  • 1. Does altering proteasomal activity and trafficking reduce the arborization mediated specific vulnerability of SNpc dopaminergic neurons of Parkinson's disease?
    Bhaskar S; Gowda J; Prasanna J; Kumar A
    Med Hypotheses; 2020 Oct; 143():110062. PubMed ID: 32652429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal 6-OHDA lesion of the SNc induces striatal compensatory sprouting from surviving SNc dopaminergic neurons without VTA contribution.
    Tanguay W; Ducrot C; Giguère N; Bourque MJ; Trudeau LE
    Eur J Neurosci; 2021 Oct; 54(7):6618-6632. PubMed ID: 34470083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.
    Giguère N; Delignat-Lavaud B; Herborg F; Voisin A; Li Y; Jacquemet V; Anand-Srivastava M; Gether U; Giros B; Trudeau LÉ
    PLoS Genet; 2019 Aug; 15(8):e1008352. PubMed ID: 31449520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.
    Pacelli C; Giguère N; Bourque MJ; Lévesque M; Slack RS; Trudeau LÉ
    Curr Biol; 2015 Sep; 25(18):2349-60. PubMed ID: 26320949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.
    Brichta L; Greengard P
    Front Neuroanat; 2014; 8():152. PubMed ID: 25565977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hTH-GFP reporter rat model for the study of Parkinson's disease.
    Iacovitti L; Wei X; Cai J; Kostuk EW; Lin R; Gorodinsky A; Roman P; Kusek G; Das SS; Dufour A; Martinez TN; Dave KD
    PLoS One; 2014; 9(12):e113151. PubMed ID: 25462571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.
    Thompson L; Barraud P; Andersson E; Kirik D; Björklund A
    J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca
    Verma A; Ravindranath V
    Front Aging Neurosci; 2019; 11():382. PubMed ID: 32009942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
    Kostuk EW; Cai J; Iacovitti L
    J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra.
    Gervais J; Rouillard C
    Synapse; 2000 Mar; 35(4):281-91. PubMed ID: 10657038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
    Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
    Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.
    Kostuk EW; Cai J; Iacovitti L
    Glia; 2019 Aug; 67(8):1542-1557. PubMed ID: 31025779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of calbindin in nigral dopaminergic neurons in two mice strains with differential susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Vidyadhara DJ; Yarreiphang H; Abhilash PL; Raju TR; Alladi PA
    J Chem Neuroanat; 2016 Oct; 76(Pt B):82-89. PubMed ID: 26775762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-Specific Transcriptome of Ventral and Dorsal Midbrain Dopamine Neurons.
    Monzón-Sandoval J; Poggiolini I; Ilmer T; Wade-Martins R; Webber C; Parkkinen L
    Ann Neurol; 2020 Jun; 87(6):853-868. PubMed ID: 32167609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate.
    Harrison IF; Anis HK; Dexter DT
    Neurosci Lett; 2016 Feb; 614():16-23. PubMed ID: 26742637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice.
    Verma A; Ray A; Bapat D; Diwakar L; Kommaddi RP; Schneider BL; Hirsch EC; Ravindranath V
    Mov Disord; 2020 Oct; 35(10):1843-1853. PubMed ID: 32618039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked differences in the number and type of synapses innervating the somata and primary dendrites of midbrain dopaminergic neurons, striatal cholinergic interneurons, and striatal spiny projection neurons in the rat.
    Sizemore RJ; Zhang R; Lin N; Goddard L; Wastney T; Parr-Brownlie LC; Reynolds JN; Oorschot DE
    J Comp Neurol; 2016 Apr; 524(5):1062-80. PubMed ID: 26355230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area.
    Krashia P; Martini A; Nobili A; Aversa D; D'Amelio M; Berretta N; Guatteo E; Mercuri NB
    Eur J Neurosci; 2017 Jan; 45(1):92-105. PubMed ID: 27519559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
    Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
    J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.